Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions

被引:39
作者
Iversen, H. [1 ,2 ]
Martling, A. [1 ,2 ]
Johansson, H. [3 ]
Nilsson, P. J. [1 ,2 ]
Holm, T. [1 ,2 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Karolinska Univ Hosp, Ctr Digest Dis, Solna P9 03, S-17176 Stockholm, Sweden
[3] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
关键词
Colorectal cancer; rectal cancer; local recurrence; locally recurrent rectal cancer; RECTAL-CANCER; PREOPERATIVE CHEMORADIOTHERAPY; EXENTERATION; MANAGEMENT; RESECTION; SURGERY; TIME;
D O I
10.1111/codi.13966
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim Although the rate of local recurrence (LR) after colorectal cancer surgery has decreased, it still poses major surgical and oncological challenges. The aims of this study, based on an audit from a tertiary referral centre, was to evaluate determinants associated with outcomes after surgery for pelvic LR and how these have changed over time. Method Retrospective analysis of all resections for pelvic LR of colorectal cancer performed at the Karolinska University Hospital from January 2003 until August 2009 (period 1) and from September 2009 until November 2013 (period 2). Results Ninety-five patients with pelvic LR were operated on with a curative intent. An R0 resection was achieved in 77% and an R1 resection in 23%. Lateral compartments were invaded in 48% and this proportion increased in resections performed in period 2 (37% vs 60%, P = 0.05). R1 resections were associated with a higher risk of local re-recurrence than R0 resections (64% vs 16%; OR = 8.90, 95% CI: 2.71-29.78). Lateral recurrences were associated with a lower R0-resection rate than nonlateral recurrences (63% vs 90%; OR = 0.20, 95% CI: 0.05-0.64) and a higher risk of treatment failure in terms of local re-recurrence or distant metastases, or death, as first event (hazard ratio [HR] = 1.75, 95% CI: 1.06-2.75). However, in a multivariate analysis only R1 resections remained a significant prognostic factor for treatment failure (HR = 2.37, 95% CI: 1.32-4.27). Conclusion The proportion of lateral pelvic recurrences has increased over time. In comparison with non-lateral LRs, lateral LRs are more difficult to resect radically and are associated with worse overall and disease-free survival. However, with radical surgery many patients with pelvic locally recurrent colorectal cancer may be offered curative treatment.
引用
收藏
页码:399 / 406
页数:8
相关论文
共 19 条
  • [1] Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer
    Akiyoshi, Takashi
    Matsueda, Kiyoshi
    Hiratsuka, Makiko
    Unno, Toshiyuki
    Nagata, Jun
    Nagasaki, Toshiya
    Konishi, Tsuyoshi
    Fujimoto, Yoshiya
    Nagayama, Satoshi
    Fukunaga, Yosuke
    Ueno, Masashi
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S614 - S620
  • [2] Selective Lateral Pelvic Lymph Node Dissection in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy Based on Pretreatment Imaging
    Akiyoshi, Takashi
    Ueno, Masashi
    Matsueda, Kiyoshi
    Konishi, Tsuyoshi
    Fujimoto, Yoshiya
    Nagayama, Satoshi
    Fukunaga, Yosuke
    Unno, Toshiyuki
    Kano, Atsuhiro
    Kuroyanagi, Hiroya
    Oya, Masatoshi
    Yamaguchi, Toshiharu
    Watanabe, Toshiaki
    Muto, Tetsuichiro
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (01) : 189 - 196
  • [3] Pelvic Exenteration with En Bloc Iliac Vessel Resection for Lateral Pelvic Wall Involvement
    Austin, Kirk K. S.
    Solomon, Michael J.
    [J]. DISEASES OF THE COLON & RECTUM, 2009, 52 (07) : 1223 - 1233
  • [4] Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes
    Bhangu, A.
    Beynon, J.
    Brown, G.
    Chang, G.
    Das, P.
    Desai, A.
    Frizelle, F.
    Glynne-Jones, R.
    Goldin, R.
    Hawkins, M. A.
    Heriot, A.
    Laurberg, S.
    Mirnezami, A.
    Nicholls, R. J.
    Sagar, P.
    Tekkis, P.
    Vuong, T.
    Wilson, M.
    Ali, S. M.
    Antoniou, A.
    Bose, P.
    Boyle, K.
    Branagan, G.
    Burling, D.
    Clark, S. K.
    Colquhoun, P.
    Crane, C. H.
    Darzi, A.
    Davies, M.
    Delaney, C. P.
    Dietz, D.
    Dozois, E. J.
    Duff, M.
    Dziki, A.
    Faria, J.
    Fitzgerald, J. E.
    Georgiou, P.
    George, B.
    George, M. L.
    Gupta, A.
    Guy, R.
    Harji, D. P.
    Harris, D. A.
    Herzig, D.
    Holm, T.
    Hompes, R.
    Jeys, L.
    Jenkins, J. T.
    Kiran, R. P.
    Koh, C. E.
    [J]. BRITISH JOURNAL OF SURGERY, 2013, 100 (08) : E1 - E33
  • [5] Bhangu A, 2014, ANN SURG, V259, P315, DOI [10.1097/SLA.0000000000000492, 10.1097/SLA.0b013e31828a0d22]
  • [6] Presentation and prognosis of local recurrence after total mesorectal excision
    de Chaisemartin, C.
    Penna, C.
    Goere, D.
    Benoist, S.
    Beauchet, A.
    Julie, C.
    Nordlinger, B.
    [J]. COLORECTAL DISEASE, 2009, 11 (01) : 60 - 66
  • [7] French current management and oncological results of locally recurrent rectal cancer
    Denost, Q.
    Faucheron, J. L.
    Lefevre, J. H.
    Panis, Y.
    Cotte, E.
    Rouanet, P.
    Jafari, M.
    Capdepont, M.
    Rullier, E.
    [J]. EJSO, 2015, 41 (12): : 1645 - 1652
  • [8] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    Dindo, D
    Demartines, N
    Clavien, PA
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
  • [9] Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma
    Gannon, Christopher J.
    Zager, Jonathan S.
    Chang, George J.
    Feig, Barry W.
    Wood, Christopher G.
    Skibber, John M.
    Rodriguez-Bigas, Miguel A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (06) : 1870 - 1877
  • [10] Time trends in the treatment and survival of recurrences from colorectal cancer
    Guyot, F
    Faivre, J
    Manfredi, S
    Meny, B
    Bonithon-Kopp, C
    Bouvier, AM
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (05) : 756 - 761